Unmet needs of biochemical biomarkers for human prion diseases

Although the development of aggregation assays has noticeably improved the accuracy of the clinical diagnosis of prion diseases, research on biomarkers remains vital. The major challenges to overcome are non-invasive sampling and the exploration of new biomarkers that may predict the onset or reflec...

Full description

Saved in:
Bibliographic Details
Main Authors: Peter Hermann, Inga Zerr
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:Prion
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/19336896.2024.2349017
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832096699512782848
author Peter Hermann
Inga Zerr
author_facet Peter Hermann
Inga Zerr
author_sort Peter Hermann
collection DOAJ
description Although the development of aggregation assays has noticeably improved the accuracy of the clinical diagnosis of prion diseases, research on biomarkers remains vital. The major challenges to overcome are non-invasive sampling and the exploration of new biomarkers that may predict the onset or reflect disease progression. This will become extremely important in the near future, when new therapeutics are clinically evaluated and eventually become available for treatment. This article aims to provide an overview of the achievements of biomarker research in human prion diseases, addresses unmet needs in the field, and points out future perspectives.
format Article
id doaj-art-becb1ff6dfbc40d48d532a58f376f7e4
institution Kabale University
issn 1933-6896
1933-690X
language English
publishDate 2024-12-01
publisher Taylor & Francis Group
record_format Article
series Prion
spelling doaj-art-becb1ff6dfbc40d48d532a58f376f7e42025-02-05T12:40:51ZengTaylor & Francis GroupPrion1933-68961933-690X2024-12-01181899310.1080/19336896.2024.2349017Unmet needs of biochemical biomarkers for human prion diseasesPeter Hermann0Inga Zerr1Department of Neurology, University Medical Center Göttingen, Göttingen, GermanyDepartment of Neurology, University Medical Center Göttingen, Göttingen, GermanyAlthough the development of aggregation assays has noticeably improved the accuracy of the clinical diagnosis of prion diseases, research on biomarkers remains vital. The major challenges to overcome are non-invasive sampling and the exploration of new biomarkers that may predict the onset or reflect disease progression. This will become extremely important in the near future, when new therapeutics are clinically evaluated and eventually become available for treatment. This article aims to provide an overview of the achievements of biomarker research in human prion diseases, addresses unmet needs in the field, and points out future perspectives.https://www.tandfonline.com/doi/10.1080/19336896.2024.2349017Biomarkerscerebrospinal fluid biomarkersCreutzfeldt-Jakob diseasediagnosisdisease onsetprion diseases
spellingShingle Peter Hermann
Inga Zerr
Unmet needs of biochemical biomarkers for human prion diseases
Prion
Biomarkers
cerebrospinal fluid biomarkers
Creutzfeldt-Jakob disease
diagnosis
disease onset
prion diseases
title Unmet needs of biochemical biomarkers for human prion diseases
title_full Unmet needs of biochemical biomarkers for human prion diseases
title_fullStr Unmet needs of biochemical biomarkers for human prion diseases
title_full_unstemmed Unmet needs of biochemical biomarkers for human prion diseases
title_short Unmet needs of biochemical biomarkers for human prion diseases
title_sort unmet needs of biochemical biomarkers for human prion diseases
topic Biomarkers
cerebrospinal fluid biomarkers
Creutzfeldt-Jakob disease
diagnosis
disease onset
prion diseases
url https://www.tandfonline.com/doi/10.1080/19336896.2024.2349017
work_keys_str_mv AT peterhermann unmetneedsofbiochemicalbiomarkersforhumanpriondiseases
AT ingazerr unmetneedsofbiochemicalbiomarkersforhumanpriondiseases